Feel like yourself again.

Yes, for appropriately evaluated women. Testosterone plays a role in women's health as well as men's. Its strongest clinical evidence is for improving sexual desire and function in appropriately selected women, particularly after menopause. Research on other outcomes is more limited, and benefits demonstrated in men cannot automatically be assumed in women. Evaluation considers your symptoms, health history, goals, and monitoring needs. Women are prescribed a small fraction of a typical male dose, with labs to keep levels in the normal female range. No testosterone product is FDA-approved for women in the US, so treatment is off-label.

Perimenopause is the transition leading up to menopause and can involve cycle and symptom changes, often starting in your 40s. Menopause is identified after twelve consecutive months without a menstrual period when another cause does not explain it. You do not have to wait until periods stop to get help.

Viva provides telehealth visits to adults who are physically located in Texas, Colorado, Florida, or Iowa at the time of care. Whether labs, an in-person exam, a retail prescription, or pharmacy delivery is part of the next step depends on the individual evaluation and applicable requirements.

Labs are ordered during your initial consultation after a review of your medical history and goals. You may provide recent lab results for your provider to review, and additional testing will be recommended when needed. Menopause itself is usually identified by your symptoms and cycle history, so testing is chosen to answer specific questions and support safe monitoring.

For healthy women under 60 or within 10 years of menopause, The Menopause Society finds that the benefits of hormone therapy generally outweigh the risks for bothersome hot flashes and for preventing bone loss. Risks depend on your age, time since menopause, health history, dose, and route; for example, estrogen through the skin carries a lower clot risk than estrogen by mouth. That is why the plan is individual.

Bioidentical means a hormone has the same chemical structure as the one your body makes. FDA-approved estradiol and micronized progesterone are bioidentical and available at retail pharmacies. The word does not mean a product is compounded, natural, safer, or better; those depend on the specific product, dose, and route.

Estradiol and progesterone can be prescribed through your retail pharmacy when appropriate. Medication costs are separate, and insurance may help cover eligible prescriptions. Compounded preparations, when prescribed, are available at an additional cost.

Hormone therapy is not a weight-loss treatment. Midlife weight change involves sleep, activity, nutrition, medications, and body-composition changes. If weight is a main concern, metabolic care can address it directly.

TRT All-Inclusive is $199 per month and is available to appropriately evaluated men and women. It includes compounded testosterone at a provider-approved dose when prescribed, supplies, home delivery, ongoing management, and two provider-selected lab panels within 12 months. Additional labs and separately prescribed medications cost extra. Compounded medications are not FDA-approved. Membership renews monthly. Cancel through the booking portal at least seven days before your next billing date. If a multi-month medication supply was already dispensed, the unpaid balance for that supply is due when you cancel.

Yes. Hormone management requires an additional membership if you're enrolled in a metabolic program. Peptide management is included with all active memberships, with peptide therapy costs separate.

Yes. You can book a symptom and quality-of-life evaluation, with decisions made case by case alongside your oncology team. Systemic menopausal hormone therapy is generally not recommended after breast cancer. Nonhormonal options are considered first for vaginal and urinary symptoms; selected patients may consider low-dose vaginal estrogen after a shared risk-benefit discussion. This is different from systemic hormone therapy. Anyone taking an aromatase inhibitor needs shared decision-making with their oncologist.